News Archives - Congruence

Congruence and Ono Announce Multi-Target Research Collaboration to Generate Small Molecule Correctors for the Treatment of Cancer

https://www.prnewswire.com/news-releases/congruence-therapeutics-announces-participation-in-barclays-biotech-1x1-private-company-symposium-302212895.html?tc=eml_cleartime

By Araceli Richardson|2024-12-03T05:02:51-08:0012.03.2024|News|0 Comments

Congruence Therapeutics Announces Blitz Talk Award and Poster Presentations on MC4R-Deficient Genetic Obesity Program at Obesity Week 2024

https://www.prnewswire.com/news-releases/congruence-therapeutics-announces-participation-in-barclays-biotech-1x1-private-company-symposium-302212895.html?tc=eml_cleartime

By Araceli Richardson|2024-11-03T09:06:59-08:0011.03.2024|News|0 Comments

Congruence Therapeutics Announces Poster Presentation on Discovery of Novel GCase Correctors for Parkinson’s Disease with GBA1 mutations at the 2024 International Congress of Parkinson’s Disease and Movement Disorders Meeting

https://www.prnewswire.com/news-releases/congruence-therapeutics-announces-participation-in-barclays-biotech-1x1-private-company-symposium-302212895.html?tc=eml_cleartime

By Araceli Richardson|2024-09-27T06:05:30-07:0009.27.2024|News|0 Comments

Congruence Therapeutics Announces Participation in Upcoming Investor Conferences

https://www.prnewswire.com/news-releases/congruence-therapeutics-announces-participation-in-barclays-biotech-1x1-private-company-symposium-302212895.html?tc=eml_cleartime

By Araceli Richardson|2024-08-29T13:08:29-07:0008.29.2024|News|0 Comments

Congruence Therapeutics Announces Participation in Barclays Biotech: 1×1 Private Company Symposium

https://www.prnewswire.com/news-releases/congruence-therapeutics-announces-participation-in-barclays-biotech-1x1-private-company-symposium-302212895.html?tc=eml_cleartime

By Araceli Richardson|2024-08-01T13:09:38-07:0008.01.2024|News|0 Comments